Windsor Creek Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$4.39M Buy
21,659
+2,741
+14% +$579K 1.33% 20
2021
Q3
$4.02M Buy
18,918
+5,852
+45% +$1.35M 1.15% 19
2021
Q2
$3.19M Sell
13,066
-1,825
-12% -$449K 0.82% 24
2021
Q1
$3.71M Sell
14,891
-3,716
-20% -$887K 0.97% 22
2020
Q4
$4.28M Buy
18,607
+7,383
+66% +$1.7M 1.08% 20
2020
Q3
$2.85M Buy
11,224
+488
+5% +$121K 0.81% 29
2020
Q2
$2.53M Buy
10,736
+2,997
+39% +$684K 0.83% 28
2020
Q1
$1.57M Sell
7,739
-3,288
-30% -$718K 0.56% 41
2019
Q4
$2.66K Sell
11,027
-1,011
-8% -$223K 0.71% 29
2019
Q3
$2.33M Buy
12,038
+3,030
+34% +$582K 0.57% 36
2019
Q2
$1.66M Sell
9,008
-6,619
-42% -$1.19M 0.45% 51
2019
Q1
$2.97M Buy
+15,627
New +$2.98M 0.8% 22

Other funds holding AMGN

Windsor Creek Advisors's AMGN Position: Q4 2021 in Review

Windsor Creek Advisors increased its Amgen (AMGN) stake by 14% in Q4 2021, buying an estimated $579K and bringing the position to 21,659 shares worth $4.39M. The position accounts for 1.33% of the portfolio, ranked #20.

Windsor Creek Advisors first reported a position in AMGN in Q1 2019 and has held it in 12 quarters since. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Windsor Creek Advisors held 21,659 shares of Amgen worth $4.39M as of Q4 2021.
  • Windsor Creek Advisors bought 2,741 Amgen shares in Q4 2021, an estimated $579K.
  • Amgen made up 1.33% of Windsor Creek Advisors's portfolio in Q4 2021, its #20 holding.
  • Windsor Creek Advisors first reported a position in Amgen in Q1 2019 and has held it in 12 quarters since.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Windsor Creek Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.